Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

Research supporting the amyloid hypothesis—the idea that Alzheimer's is caused by a buildup of amyloid plaques in the ...

Scientists believe they have found a major link between Alzheimer's disease and a dieting hack, which is followed by millions ...

Charles Piller, author of the new book Doctored, says the scientific community needs “to take a good hard look in the mirror.

Alzheimer’s disease, the most common form of dementia affecting more than three million Americans a year, has proven difficult to diagnose in earlier stages. But detecting and treating the condition ...

The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Leqembi (lecanemab) and Kisunla (donanemab) are proven to slow cognitive and functional decline by 27 and 35%, respectively.